Roche Finally Gets A Nod With $3.4 Billion Bid For Ventana
This article was originally published in The Pink Sheet Daily
Executive Summary
After seven months and a half dozen attempts to acquire the diagnostics company, Roche wins over Ventana’s board with a sweetened bid .
You may also be interested in...
Sanofi/Genzyme Saga: War Before Peace?
Unless a white knight bidder emerges to thwart Sanofi-Aventis' attempt to acquire Genzyme, and soon, the Cambridge-Mass.-based biotech's best negotiating tactic may be stalling.
Sanofi/Genzyme Saga: War Before Peace?
Unless a white knight bidder emerges to thwart Sanofi-Aventis' attempt to acquire Genzyme, and soon, the Cambridge-Mass.-based biotech's best negotiating tactic may be stalling.
Sanofi Forces Genzyme's Hand With Hostile Bid
With no white knight in Genzyme's corner, Sanofi commences a tender offer for Genzyme at $69-per-share.